Therapeutic Potential of Polyphenols-Loaded Polymeric Nanoparticles in Cardiovascular System.
Olga PechanovaEzgi DayarMartina CebovaPublished in: Molecules (Basel, Switzerland) (2020)
Numerous studies document an increased production of reactive oxygen species (ROS) with a subsequent decrease in nitric oxide (NO) bioavailability in different cardiovascular diseases, including hypertension, atherosclerosis, and heart failure. Many natural polyphenols have been demonstrated to decrease ROS generation and/or to induce the endogenous antioxidant enzymatic defense system. Moreover, different polyphenolic compounds have the ability to increase the activity/expression of endothelial nitric oxide synthase (eNOS) with a subsequent enhancement of NO generation. However, as a result of low absorption and bioavailability of natural polyphenols, the beneficial effects of these substances are very limited. Recent progress in delivering polyphenols to the targeted tissues revealed new possibilities for the use of polymeric nanoparticles in increasing the efficiency and reducing the degradability of natural polyphenols. This review focuses on the effects of different natural polyphenolic substances, especially resveratrol, quercetin, curcumin, and cherry extracts, and their ability to bind to polymeric nanoparticles, and summarizes the effects of polyphenol-loaded nanoparticles, mainly in the cardiovascular system.
Keyphrases
- nitric oxide synthase
- drug delivery
- nitric oxide
- cancer therapy
- reactive oxygen species
- heart failure
- cardiovascular disease
- drug release
- cell death
- hydrogen peroxide
- blood pressure
- poor prognosis
- endothelial cells
- oxidative stress
- drinking water
- gene expression
- metabolic syndrome
- type diabetes
- cell proliferation
- atrial fibrillation
- cardiovascular risk factors
- binding protein
- cardiovascular events